Michael Shen has advised innovative life sciences companies as well as venture capital, private equity and other firms that invest in those companies on China/US-related corporate and securities transactions, including company formations, spin-offs, venture capital financing, private equity investments, mergers and acquisitions, joint ventures and other strategic transactions, employee equity incentives, corporate governance matters and other general corporate matters.
